Literature DB >> 10654967

Oxygen therapy, oxygen toxicity, and the STOP-ROP trial.

W W Hay, E F Bell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10654967     DOI： 10.1542/peds.105.2.424

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  5 in total

1.  NICU bedside caregivers sustain process improvement and decrease incidence of bronchopulmonary dysplasia in infants < 30 weeks gestation.

Authors:  Sara J Mola; David J Annibale; Carol L Wagner; Thomas C Hulsey; Sarah N Taylor
Journal:  Respir Care       Date:  2014-11-25       Impact factor: 2.258

2.  Hyperoxia-induced p47phox activation and ROS generation is mediated through S1P transporter Spns2, and S1P/S1P1&2 signaling axis in lung endothelium.

Authors:  Anantha Harijith; Srikanth Pendyala; David L Ebenezer; Alison W Ha; Panfeng Fu; Yue-Ting Wang; Ke Ma; Peter T Toth; Evgeny V Berdyshev; Prasad Kanteti; Viswanathan Natarajan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-24       Impact factor: 5.464

Review 3.  Oxygen therapy for infants with chronic lung disease.

Authors:  S Kotecha; J Allen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

4.  Sphingosine kinase 1 regulates lysyl oxidase through STAT3 in hyperoxia-mediated neonatal lung injury.

Authors:  Alison W Ha; Tao Bai; David L Ebenezer; Tanvi Sethi; Tara Sudhadevi; Lizar Ace Mangio; Steven Garzon; Gloria S Pryhuber; Viswanathan Natarajan; Anantha Harijith
Journal:  Thorax       Date:  2021-04-21       Impact factor: 9.102

5.  c-abl is required for the development of hyperoxia-induced retinopathy.

Authors:  I Nunes; R D Higgins; L Zanetta; P Shamamian; S P Goff
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.